What is Prevention Settlement
Prevention Settlement — Converting Preventive Care into Billable Evidence
Prevention Settlement converts the health improvements from preventive interventions into formally reimbursable items via standardized causal evidence. The key is causation, not correlation — proving the intervention itself caused health improvement, not merely a statistical association.
📅 Last updated: April 2026
✍️ ReHealth Core Research Team
🔬 Real-world study methods · PSM
Why Prevention Has Been Hard to Settle
Preventive medicine faces a fundamental commercial paradox: successful prevention means "nothing happened". No diagnosis, no treatment, no trigger point for traditional medical billing.
This paradox creates four structural barriers:
Barrier 01
No Standardized Proof Path
Traditional billing relies on ICD codes and defined charge items. Preventive interventions have neither, leaving payers with no framework to apply.
Barrier 02
Effect Hard to Causally Attribute
Even if the intervention group is healthier, selection bias cannot be ruled out. Without causal evidence, payers won't pay.
Barrier 03
Beneficiary-Payer Misalignment
Employers pay for prevention, but insurers benefit from lower claims. No shared evidence currency exists between the three parties.
Barrier 04
Time Window Mismatch
Prevention effects take months to years to appear in medical costs, while payer budget cycles are annual. No cross-period settlement mechanism exists.
Standard Definition of Prevention Settlement
A complete prevention settlement requires four conditions:
01
Quantifiable Health Outcome Change
Measurable health metric changes before and after intervention (e.g., cardiovascular risk score reduction, lower hospitalization rates, reduced medical costs).
02
Causally Verified Intervention Effect
PSM propensity score matching confirms that health improvements are statistically attributable to the intervention itself after eliminating confounders and selection bias.
03
Standardized Evidence Documentation
Generate causal reports compliant with RWE methodology standards, including ATT (Average Treatment Effect), confidence intervals, matching methodology, and data sources.
04
Payer Evaluation and Settlement Discussion
Evidence packages provide traceable input for payer evaluation, program discussions, and pilot design; adoption and financial arrangements depend on the relevant policies and agreements.
How ReHealth Core Enables Prevention Settlement
预测 → 干预 → 归因 → 结算 — This is not four independent modules but a causal chain. Remove any link and settlement fails. This is what fundamentally differentiates ReHealth Core from tools that stop at prediction.
Stakeholder Roles in Prevention Settlement
🛡️
Insurance Companies
May use project data, study design, effect estimates, and limitations for health-management program evaluation and partnership discussion. Premium, claims, and reinsurance terms are independently decided by the relevant parties within applicable rules and contracts.
🏢
Enterprise Employers
Use project materials for health-management review, service improvement, and partnership discussion; cost, absence, and productivity metrics are independently evaluated by the relevant parties from project data.
🏥
Healthcare Institutions
Use auditable evidence for internal evaluation, collaborative program design, and communication with commercial health insurers. This stage does not rely on incremental public-insurance payment or DRG settlement pathways.
💊
Pharmaceutical Companies
Support real-world studies and evidence organization using intervention trajectories. Drug or device registration submissions require separate work under applicable NMPA requirements.
Frequently Asked Questions
How is prevention settlement different from traditional medical billing?
Traditional billing covers treatment of existing diseases with ICD codes and defined charges. Prevention settlement covers interventions for diseases that haven't occurred yet, requiring quantifiable causal evidence to prove to payers that the intervention actually reduced health risk.
Why can't correlation be used for settlement?
People who participate in health management programs are already healthier than those who don't (selection bias). Simple correlation cannot distinguish whether the intervention was effective or whether healthier people self-selected into the program. Payers need causal evidence — how much did the intervention group actually improve compared to matched controls after baseline differences are eliminated.
Is prevention settlement supported by policy in China?
China's National Healthcare Security Administration has repeatedly expressed support for incorporating preventive interventions into payment systems, and NMPA has issued RWE guidelines. As of 2026, a systematic prevention settlement framework is still in the policy exploration phase. ReHealth Core's strategy is to first validate prevention settlement through commercial insurance and employers, then penetrate the public insurance system.
Related Concepts
Key Takeaway
The core barrier to preventive medicine settlement has never been technology — it's what evidence the payment system accepts. Correlation data will be rejected by actuaries; PSM causal evidence can be formally accepted. This methodological gap is the true reason preventive medicine has stagnated commercially for a decade.